These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9374381)

  • 1. Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069.
    Patterson AV; Saunders MP; Chinje EC; Talbot DC; Harris AL; Strafford IJ
    Br J Cancer; 1997; 76(10):1338-47. PubMed ID: 9374381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).
    Patterson AV; Barham HM; Chinje EC; Adams GE; Harris AL; Stratford IJ
    Br J Cancer; 1995 Nov; 72(5):1144-50. PubMed ID: 7577460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line.
    Saunders MP; Patterson AV; Chinje EC; Harris AL; Stratford IJ
    Br J Cancer; 2000 Feb; 82(3):651-6. PubMed ID: 10682679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
    Keohane A; Godden J; Stratford IJ; Adams GE
    Br J Cancer; 1990 May; 61(5):722-6. PubMed ID: 2110815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity.
    Elwell JH; Siim BG; Evans JW; Brown JM
    Biochem Pharmacol; 1997 Jul; 54(2):249-57. PubMed ID: 9271329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-nuclear localized human NOSII enhances the bioactivation and toxicity of tirapazamine (SR4233) in vitro.
    Chinje EC; Cowen RL; Feng J; Sharma SP; Wind NS; Harris AL; Stratford IJ
    Mol Pharmacol; 2003 Jun; 63(6):1248-55. PubMed ID: 12761334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NADPH-cytochrome p450 reductase overexpression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines.
    Ramji S; Lee C; Inaba T; Patterson AV; Riddick DS
    Cancer Res; 2003 Oct; 63(20):6914-9. PubMed ID: 14583491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?
    Chinje EC; Patterson AV; Saunders MP; Lockyer SD; Harris AL; Stratford IJ
    Br J Cancer; 1999 Dec; 81(7):1127-33. PubMed ID: 10584872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, WIN 59075, SR 4233) to a DNA-damaging species: a direct role for NADPH:cytochrome P450 oxidoreductase.
    Fitzsimmons SA; Lewis AD; Riley RJ; Workman P
    Carcinogenesis; 1994 Aug; 15(8):1503-10. PubMed ID: 8055626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial characterization of the major mouse cytochrome P450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-di-N-oxide (tirapazamine, SR 4233, WIN 59075).
    Riley RJ; Hemingway SA; Graham MA; Workman P
    Biochem Pharmacol; 1993 Mar; 45(5):1065-77. PubMed ID: 8461036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of DT-diaphorase and hypoxia in the cytotoxicity of RH1 in human breast and non-small cell lung cancer cell lines.
    Kim JY; Patterson AV; Stratford IJ; Hendry JH
    Anticancer Drugs; 2004 Jan; 15(1):71-7. PubMed ID: 15090746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the comet assay to detect hypoxic cells in murine tumours and normal tissues exposed to bioreductive drugs.
    Olive PL
    Acta Oncol; 1995; 34(3):301-5. PubMed ID: 7779413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cytochrome P450 and cytochrome P450 reductase in the reductive bioactivation of the novel benzotriazine di-N-oxide hypoxic cytotoxin 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233, WIN 59075) by mouse liver.
    Walton MI; Wolf CR; Workman P
    Biochem Pharmacol; 1992 Jul; 44(2):251-9. PubMed ID: 1642640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines.
    Cahill A; White IN
    Carcinogenesis; 1990 Aug; 11(8):1407-11. PubMed ID: 2117504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233).
    Patterson AV; Robertson N; Houlbrook S; Stephens MA; Adams GE; Harris AL; Stratford IJ; Carmichael J
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):369-72. PubMed ID: 8195035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin.
    Koch CJ
    Cancer Res; 1993 Sep; 53(17):3992-7. PubMed ID: 8358728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents.
    Garner AP; Paine MJ; Rodriguez-Crespo I; Chinje EC; Ortiz De Montellano P; Stratford IJ; Tew DG; Wolf CR
    Cancer Res; 1999 Apr; 59(8):1929-34. PubMed ID: 10213502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro oxygen-dependent survival of 2 human cell lines after radiation combined with tirapazamine (SR-4233) and cisplatin].
    Lartigau E; Stern S; Guichard M
    Cancer Radiother; 2000; 4(3):217-22. PubMed ID: 10897765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does tirapazamine (SR-4233) have any cytotoxic or sensitizing effect on three human tumour cell lines at clinically relevant partial oxygen pressure?
    Lartigau E; Guichard M
    Int J Radiat Biol; 1995 Feb; 67(2):211-6. PubMed ID: 7884290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.